Form 4: Bio-Key International Director Acquires Shares in Lieu of Board Meeting Fees

Emmanuel Alia, a director at Bio-Key International, acquired 2,587 shares of common stock as payment for board meeting attendance fees.

Summary

• On November 7, 2024, Emmanuel Alia, a director of Bio-Key International, acquired 2,587 shares of common stock.
• The shares were issued under the company's 2023 Stock Incentive Plan as payment for board meeting attendance fees.
• Following the transaction, Alia directly owns 9,455 shares of Bio-Key International.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director taking shares instead of cash shows confidence in the company's future, but the amount is relatively small and doesn't indicate a major shift in outlook.

Positives

• The acquisition of shares by a director demonstrates their continued investment in the company's success.

Industry Context

Directors receiving stock in lieu of cash compensation is a fairly common practice, especially for smaller companies, as it helps conserve cash and aligns the interests of the directors with those of the shareholders.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.

Key Dates

Keywords

Bio-Key International, Director, Emmanuel Alia, Stock Incentive Plan, Board Meeting Fees, Share Acquisition, Form 4, BKYI